How often does ADHD coexist with substance use disorder?
Recent UK and international evidence show that substance use disorder (SUD) is significantly more common in people with ADHD than in the general population. According to national guidance and large cohort studies, ADHD not only increases the likelihood of developing SUD but also contributes to earlier onset and more severe patterns of addiction.
How common is SUD in ADHD?
Studies published in BMJ and PubMed show that around 23% of people in addiction services have ADHD, compared with far lower rates in the wider population (PMC, 2023; PMC, 2024). UK cohort studies indicate that 10–25% of individuals diagnosed with ADHD will experience a substance use disorder at some point in their lives.
Cannabis is the most frequently reported illicit substance, but alcohol, nicotine and stimulant misuse are also markedly higher in people with ADHD. Research consistently shows that individuals with ADHD start using substances earlier, often during early adolescence (PMC).
Who is most affected?
Both males and females with ADHD face elevated risk, though some studies show slightly higher prevalence in males. NHS England’s 2025 ADHD Taskforce notes that the 11–24 age group is particularly vulnerable, with early substance use often linked to impulsivity, emotional dysregulation, and environmental pressures (NHS England).
What do NHS and NICE guidelines say?
NICE recommends routine screening for substance misuse in all ADHD assessments and during ongoing care, citing strong evidence of increased vulnerability (NICE NG87). NHS England echoes this, emphasising the need for early intervention and integrated mental health support across childhood, adolescence and adulthood.
The Royal College of Psychiatrists also highlights the importance of recognising ADHD in addiction services, as undiagnosed ADHD can lead to more rapid escalation of substance use.
Why do ADHD and SUD often coexist?
Shared mechanisms help explain the strong overlap. These include impulsivity, dopamine dysregulation, difficulties with self-regulation, and the tendency to use substances for emotional coping or self-medication. Co-occurring conditions such as anxiety, oppositional defiant disorder, and conduct disorder further increase the likelihood of SUD in ADHD.
Nicotine dependence is particularly pronounced: people with ADHD are more than twice as likely to smoke and become dependent.Cannabis and alcohol misuse also occur at significantly higher rates.
Does treatment reduce risk?
Yes. Evidence from BMJ shows that ADHD medication is associated with lower long-term risk of substance misuse, likely because it improves impulse control, attention and emotional stability (BMJ, 2024). Combining medication with psychological therapy and psychoeducation offers the strongest protection.
Takeaway
SUD is much more common in people with ADHD, affecting up to one in four individuals in addiction treatment. But early diagnosis, evidence-based medication, and structured psychological support can significantly reduce this risk and support healthier, more stable long-term outcomes.
